Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (111)	3/1/2002 7:38:07 PM
From: Jibacoa	Read Replies (2) \| Respond to of 544

Well, it is nice to see some Biotechs having double digits up-moves, something thhat we had been missing for a while.<g> Today we had ADRX (the Ft.Lauderdale Co. <g>) up 25.29% fully closing the Feb.22 down-gap after a court dismissed Glaxo's claim and the company apparently will be able to start marketing generics for Wellbutrin and Zyban with 180 days "exclusve".<g> EDEN was up 11.59% on volume of 197,800 of course it was selling earlier this week about 0.5 of book and below its cash/share.<g> IMCL up 21.73% on volume of 14,015,800 (about double its average).<g> with help of the general market and yesterday's article on WSJ.<g> Erbitux is probably a good anticancer drug and the FDA may get to review it.<g> NPRO Up 15.90%,albeit volume was less than its average.<g> PHMD up 34% on volume of 695,900 (about 3x its average.<g>)after its PhotoMex Laser (used for psoriatic and other skin lesions) had approval of CPT code reimbursement as requested by the Academy of Dermatology.<g> VLTS up 36.36% on volume of 202,400 apparently as a one week late reaction to its CEO, Dr. Benjamin F. McGraw, III, presentation at the 2002 BIO CEO & Investor Conference held at the Waldorf.<g> TWTI (It didn't quite make it to the double digits gainers list, as it was up only 9.39%.<g>)on volume of 238,600 about 1.8x its average.<g>It has reported on Tuesday that its revenues for the year ended Dec. 31, 2001 ($34.1 M) were an increase of 199% from the $11.4 million of 2000.And its Invader genetic analysis sales increased to $30.4 million for fiscal year 2001, up from $10.9 million in 2000. siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com Bernard